LYTT Competitors

Quantum maximizes performance and reduces long-term storage costs by uniquely bringing together high-performance storage, disk, and tape into a single platform that continuously aligns data with the most appropriate storage technology.

InsightFinder is an end-to-end AI and IT reliability platform that covers detection, prediction, and resolution across your entire infrastructure and application stack. You get one system instead of a patchwork of point tools: unsupervised machine learning for anomaly detection, predictive analytics that flag incidents before they happen, and automated root cause analysis that tells your team what broke and why. That end-to-end coverage means your SRE and DevOps teams stop stitching together data from separate monitoring, logging, and alerting tools. InsightFinder ingests metrics, logs, and traces from across your environment and correlates them automatically, so reliability engineering runs as one workflow instead of five. Enterprise teams in finance, telecom, healthcare, and retail rely on InsightFinder to reduce mean time to resolution and move from reactive firefighting to proactive reliability management. Founded in 2015, with our headquarters in Raleigh, NC.

Osiris Therapeutics, Inc. was founded in 1992 based on stem cell technology discovered by researchers at Case Western Reserve University led by Dr. Arnold Caplan. He recognized this technology had tremendous therapeutic potential. Today, more than two decades after the journey began, Osiris continues to advance the science of cellular regenerative medicine to treat patients in need. Osiris Therapeutics, based in Columbia, Maryland, is the world leader in researching, developing and marketing regenerative medicine products. Having developed the world’s first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine – including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4™, Cartiform® and Grafix®. Osiris, Grafix, and Cartiform are registered trademarks of Osiris Therapeutics, Inc. BIO4 is a trademark of Stryker Corporation (NYSE: SYK). More information can be found on the company's website, www.Osiris.com.